Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
International N&H Denmark A/S is the Danish operating entity of IFF's Health & Biosciences division, formed following the 2021 merger between IFF and DuPont's Nutrition & Biosciences business. Headquartered in Brabrand, Denmark, the company occupies the historic site of Danisco and serves as a global hub for biotechnology and food science R&D. The company specializes in the development and production of enzymes, cultures, and probiotics that enhance the health, texture, and sustainability of food, beverage, and pharmaceutical products. Its core focus is on the human microbiome, leveraging advanced fermentation technologies to produce clinically documented probiotic strains under the HOWARU brand. International N&H Denmark plays a critical role in IFF's global strategy to provide bio-based solutions for the health and wellness markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International N&H Denmark.